2m 2m 2m 2m 2m 2m 2m
AVANTOR (AVTR)
NYSE
$9.42+$0.07 (+0.75%)
Price as of Jun 23, 2026 5:01 PM EDT- $6.4BMarket Cap
- -30.38%1-Year Change
- Medical Instruments & SuppliesIndustry
AVANTOR (AVTR)
$9.42+$0.07 (+0.75%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.6B -3.41% | 6.8B -2.64% | 7.0B -7.26% | 7.5B +1.71% | |
Cost of Revenue | 4.4B -2.03% | 4.5B -2.15% | 4.6B -6.24% | 4.9B +0.54% | |
Gross Profit | 2.1B -6.14% | 2.3B -3.57% | 2.4B -9.18% | 2.6B +4.00% | |
Sales and Marketing Expense | 1.6B -2.78% | 1.6B +8.93% | 1.5B +2.31% | 1.5B -3.78% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 410.2M +1.16% | 405.5M +0.80% | 402.3M -0.79% | 405.5M +6.94% | |
Total Operating Expenses | 4.4B -2.03% | 4.5B -2.15% | 4.6B -6.24% | 4.9B +0.54% | |
Operating Profit | -246.2M -122.70% | 1.1B +55.77% | 696.4M -38.38% | 1.1B +16.25% | |
Interest Income | 42.2M -43.81% | 75.1M +15.18% | 65.2M +32,500.00% | 200,000 -86.67% | |
Interest Expense | N/A N/A | N/A N/A | -284.8M +7.15% | -265.8M +22.26% | |
Interest Income and Expense and Net | 42.2M -43.81% | 75.1M +134.20% | -219.6M -17.32% | -265.6M +23.02% | |
Total Nonoperating Income and Expense | -20.7M +1,625.00% | -1.2M -120.69% | 5.8M +825.00% | -800,000 -107.55% | |
Income before Taxes | -441.3M -151.68% | 853.9M +108.01% | 410.5M -51.77% | 851.1M +13.03% | |
Income Taxes | 88.9M -37.57% | 142.4M +59.28% | 89.4M -45.69% | 164.6M -8.76% | |
Extraordinary Items | 785.0M N/A | 0 -100.00% | 160.8M N/A | N/A N/A | |
Net Income | -530.2M -174.52% | 711.5M +121.58% | 321.1M -53.23% | 686.5M +19.89% | |
Net Income from Continuing Operations Applicable to Common | -441.3M -162.02% | 711.5M +121.58% | 321.1M -51.52% | 662.3M +30.37% | |
Basic EPS and Net Income | -0.78 -174.29% | 1.05 +118.75% | 0.48 -52.94% | 1.02 +18.60% | |
Diluted EPS and Net Income | -0.78 -175.00% | 1.04 +121.28% | 0.47 -53.47% | 1.01 +18.82% | |
Basic Weighted Average Shares | 680.6M +0.15% | 679.6M +0.59% | 675.6M +3.79% | 650.9M +10.23% | |
Diluted Weighted Average Shares | 680.6M -0.19% | 681.9M +0.52% | 678.4M -0.15% | 679.4M +13.31% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 365.4M +39.52% | 261.9M -0.38% | 262.9M -29.50% | 372.9M +23.60% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 365.4M +39.52% | 261.9M -0.38% | 262.9M -29.50% | 372.9M +23.60% | |
Total Current Assets | 2.5B +14.19% | 2.1B -9.99% | 2.4B -10.27% | 2.7B +7.29% | |
Accumulated Depreciation | 744.7M +18.30% | 629.5M +2.04% | 616.9M +19.00% | 518.4M +16.44% | |
Property and Plant and Equipment and Net | 766.8M +8.29% | 708.1M -3.99% | 737.5M +1.44% | 727.0M +3.05% | |
Total Long-Term Assets | 396.0M +9.88% | 360.4M +0.59% | 358.3M +22.08% | 293.5M +25.91% | |
Total Assets | 11.8B -2.64% | 12.1B -6.62% | 13.0B -3.65% | 13.5B -3.12% | |
Income Taxes Payable | 557.1M -0.04% | 557.3M -9.06% | 612.8M -16.22% | 731.4M -19.89% | |
Total Short-Term Debt | 30.8M -96.25% | 821.1M +215.93% | 259.9M -28.64% | 364.2M +705.75% | |
Total Current Liabilities | 1.4B -31.31% | 2.0B +35.61% | 1.5B -10.76% | 1.7B +14.34% | |
Total Long-Term Debt | 3.9B +21.05% | 3.2B -38.70% | 5.3B -10.92% | 5.9B -15.11% | |
Total Long-Term Liabilities | 378.2M +5.55% | 358.3M +2.28% | 350.3M +18.58% | 295.4M -17.58% | |
Total Liabilities | 6.2B +1.17% | 6.2B -20.24% | 7.7B -10.32% | 8.6B -11.25% | |
Retained Earnings | 1.7B -24.07% | 2.2B +47.70% | 1.5B +27.44% | 1.2B +141.87% | |
Total Stockholders Equity | 5.6B -6.58% | 6.0B +13.40% | 5.3B +8.18% | 4.9B +15.69% | |
Total Shares Outstanding | 682.0M +0.18% | 680.8M +0.62% | 676.6M +0.34% | 674.3M +10.60% | |
Cash Flow | |||||
Cash from Operating Activities | 623.8M -25.81% | 840.8M -3.36% | 870.0M +3.13% | 843.6M -11.54% | |
Capital Expenditures | 128.8M -13.44% | 148.8M +1.64% | 146.4M +9.75% | 133.4M +20.07% | |
Cash from Investing Activities | -130.5M -129.73% | 438.9M +405.43% | -143.7M +31.11% | -109.6M -97.34% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -409.4M -68.05% | -1.3B +51.85% | -843.7M +30.06% | -648.7M -120.15% | |
Financials Ratio | |||||
Gross Margin | 32.65% -2.82% | 33.60% -0.96% | 33.93% -2.08% | 34.65% +2.25% | |
Operating Margin | -3.76% -123.50% | 15.99% +59.99% | 10.00% -33.56% | 15.04% +14.30% | |
Return on Assets | -4.44% -178.19% | 5.67% +133.50% | 2.43% -51.59% | 5.02% +4.30% | |
Return on Equity | -9.20% -172.50% | 12.69% +99.81% | 6.35% -58.11% | 15.17% -9.00% | |
Revenue Growth | -3.41% +29.45% | -2.64% -63.69% | -7.26% -524.40% | 1.71% -88.98% | |
Current Ratio | 1.78 +66.24% | 1.07 -33.63% | 1.61 +0.55% | 1.60 -6.16% | |
Cash Ratio | 0.27 +103.07% | 0.13 -26.52% | 0.18 -21.00% | 0.22 +8.08% | |
Debt-to-Equity Ratio | 0.71 +4.14% | 0.68 -35.40% | 1.05 -18.60% | 1.29 -22.62% | |
Debt-to-Assets Ratio | 0.33 -0.06% | 0.33 -21.56% | 0.43 -8.61% | 0.47 -7.60% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow